BMY FY 2020 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2020 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$42.5B+62.6% YoY

Gross Profit

$21.7B51.0% margin

Operating Income

$4.5B10.6% margin

Net Income

-$9.0B-21.2% margin

EPS (Diluted)

$-3.98

Cash Flow

Operating Cash Flow

$14.1B

Free Cash Flow

$13.3B

Stock-Based Comp.

$779M

Balance Sheet

Total Assets

$118.5B

Total Liabilities

$80.6B

Stockholders' Equity

$37.8B

Cash & Equivalents

$14.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42.5B	$26.1B	+62.6%
Gross Profit	$21.7B	$17.3B	+25.8%
Operating Income	$4.5B	$6.4B	-30.2%
Net Income	-$9.0B	$3.4B	-361.6%